Summary
Protein binding of chlorpromazine, propranolol, meperidine, desipramine, salicylic acid and phenytoin was determined in plasma of 64 healthy volunteers (35 males and 29 females). An attempt was made to identify factors affecting the plasma protein binding of these drugs. Whereas plasma albumin levels decreased as a function of age in both sexes, α1-acid glycoprotein levels increased with age, but the increase was more pronounced in males. The free plasma fraction of the acidic drugs (salicylic acid, phenytoin) and despiramine (a base) showed a significant (p<0.005) negative correlation with plasma albumin levels. The free fractions of the other three basic drugs (chlorpromazine, propranolol, meperidine) in plasma showed a significant (p<0.005) negative correlation with α1-acid glycoprotein plasma levels. Plasma protein binding of salicylic acid, phenytoin and desipramine decreased as a function of age. Plasma protein binding of chlorpromazine, propranolol and meperidine was virtually unaffected by age or was slightly increased (chlorpromazine). Only in the case of salicylic acid could a statistically significant difference be demonstrated between males and females in the free fraction-age relationship. Stepwise multiple linear regression analysis, including age and blood chemistry values such as hematocrit, bilirubin, cholesterol, triglycerides, creatinine, BUN, albumin and α1-acid glycoprotein as independent variables, identified age as the variable explaining most of the variability in plasma binding of salicylic acid, phenytoin and desipramine. For chlorpromazine, propranolol and meperidine α1-acid glycoprotein was the most important determinant of plasma protein binding.
Similar content being viewed by others
References
Abel JG, Sellers EM, Naranjo CA, Shaw J, Kadan D, Romach MK (1979) Inter- and intra-subject variation in diazepam free fraction. Clin Pharmacol Ther 26: 247–255
Abramson FP, Jenkins J, Ostchega Y (1982) Effects of cancer and its treatments on plasma concentration of alpha1-acid glycoprotein and propranolol binding. Clin Pharmacol Ther 32: 659–663
Adir J, Miller AK, Vestal RE (1982) Effects of total plasma concentration and age on tolbutamide plasma protein binding. Clin Pharmacol Ther 31: 488–493
Allen MD, Greenblatt DJ, Harmatz JS, Shader RI (1980) Desmethyldiazepam kinetics in the elderly after oral prazepam. Clin Pharmacol Ther 28: 196–202
Bender AD, Post A, Meier JP, Higson JE, Reichard G (1975) Plasma protein binding of drugs as a function of age in adult human subjects. J Pharm Sci 64: 1711–1713
Blain PG, Mucklow JC, Rawlins MD, Roberts DF, Routledge PA, Shand DG (1981) Determinants of plasmaα 1-acid glycoprotein concentrations in health. Br J Clin Pharmacol 12: 275 P
Braithwaite RA, Heard R, Snape A (1978) Plasma protein binding of maprotiline in geriatric patients — influence of α1-acid glycoprotein. Br J Clin Pharmacol 6: 448–449
Cammarata RJ, Rodman GP, Fennell RH (1967) Serum anti-gamma globulin and anti-nuclear factors in the aged. J Am Med Assoc 199: 115–118
Divoll M, Greenblatt DJ, Harmatz JS, Shader RI (1981) Effect of age and gender on disposition of temazepam. J Pharm Sci 70: 1104–1107
Greenblatt DJ, Allen MD, Harmatz JS, Shader RI (1980) Diazepam disposition determinants. Clin Pharmacol Ther 27: 301–312
Greenblatt DJ, Divoll M, Harmatz JS, Shader RI (1980) Oxazepam kinetics: effects of age and sex. J Pharmacol Exp Ther 215: 86–91
Greenblatt DJ, Divoll M, Harmatz JS, MacLaughlin DS, Shader RI (1981) Kinetics and clinical effects of flurazepam in young and elderly non-insomniacs. Clin Pharmacol Ther 30: 475–486
Greenblatt DJ, Divoll M, Puri SK, Ho I, Zinay MA, Shader RI (1981) Clobazam kinetics in the elderly. Br J Clin Pharmacol 12: 631–636
Greenblatt DJ, Divoll M, Abernathy DR, Maschitto LJ, Smith RB, Shader RI (1983) Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. Br J Clin Pharmacol 15: 303–309
Hayes MJ, Langman MJS, Short AH (1975) Changes in drug metabolism with age. I. Warfarin binding and plasma proteins. Br J Clin Pharmacol 2: 69–72
Hayes MJ, Langman MJS, Short AH (1975) Changes in drug metabolism with increasing age. 2. Phenytoin clearance and protein binding. Br J Clin Pharmacol 2: 73–79
Holmberg L, Odar-Cederlöf I, Nilsson JLG, Ehrnebo M, Boréus LO (1982) Pethidine binding to blood cells and plasma proteins in old and young subjects. Eur J Clin Pharmacol 23: 457–461
Hooper WD, Bochner F, Eadie MJ, Tyrer JH (1974) Plasma protein binding of diphenylhydantoin: effects of sex hormones, renal and hepatic disease. Clin Pharmacol Ther 15: 276–282
Koch-Weser J, Sellers EM (1976) Binding of drugs to serum albumin. New Engl J Med 294: 311–316, 526–531
Lesko LJ, Yeager RL, Narang PK, Hodes JE, Cutler NR (1983) Salicylate protein binding in young and elderly serum as measured by diafiltration. Clin Pharmacol Ther 33: 257 (Abstract A14)
Mancini G, Carbouara AO, Heremans JF (1965) Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235–254
Mather LE, Tucker GT, Pflug AE, Lindop MJ, Wilkerson C (1975) Meperidine kinetics in man: intravenous injection in surgical patients and volunteers. Clin Pharmacol Ther 17: 21–30
Miaskiewicz SL, Shirley CA, Vesell ES (1982) Sex differences in absorption kinetics of sodium salicylate. Clin Pharmacol Ther 31: 30–37
Mitchard M (1979) Drug distribution in the elderly. In: Crooks J, Stevenson IH (eds) Drugs and the elderly: perspectives in geriatric clinical pharmacology. MacMillan, London
Neter J, Wasserman W (1974) Applied linear statistical models. Richard D Irwin Inc., Homewood, Illinois
Patterson M, Heazelwood R, Smithurst B, Eadie MJ (1982) Plasma protein binding of phenytoin in the aged: in vivo studies. Br J Clin Pharmacol 13: 423–425
Peterson GM, McLean S, Aldous S, von Witt RJ, Millingen KS (1982) Plasma protein binding of phenytoin in 100 epileptic patients. Br J Clin Pharmacol 14: 298–300
Piafsky KM (1980) Disease-induced changes in plasma binding of basic drugs. Clin Pharmacokinet 5: 246–262
Piafsky KM, Borgå O, Odar-Cederlöf I, Johansson C, Sjöqvist F (1978) Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma α1-acid glycoprotein. New Engl J Med 299: 1435–1439
Reidenberg MM, Odar-Cederlöf I, Bahr C, Borgå O, Sjöqvist F (1971) Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. New Engl J Med 285: 264–267
Roberts RK, Desmond PV, Wilkinson GR, Schenker S (1979) Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives. Clin Pharmacol Ther 25: 826–831
Routledge PA, Stargel WW, Kitchell BB, Barchowsky A, Shand DG (1981) Sex-related differences in the plasma protein binding of lignocaine and diazepam. Br J Clin Pharmacol 11: 245–250
Rowell FJ, Hui SM, Fairbairn AF, Ecceleston D (1981) Total and free serum haloperidol levels in schizophrenic patients and the effect of age, thioridazine and fatty acids on haloperidol-serum protein binding in vivo. Br J Clin Pharmacol 11: 377–382
Shand DG (1982) Biological determinants of altered pharmacokinetics in the elderly. Gerontology 28 [Suppl 1]: 8–17
Verbeeck RK, Cardinal J, Hill AG, Midha KK (1983) Binding of phenothiazine neuroleptics to plasma proteins. Biochem Pharmacol 32: 2565–2570
Verbeeck RK, Cardinal J-A (1984) Plasma protein binding of salicylic acid, phenytoin, chlorpromazine, propranolol and meperidine using equilibrium dialysis and ultracentrifugation. Arzneimittelforsch (in press)
Vestal RE (1978) Drug use in the elderly: a review of problems and special considerations. Drugs 16: 358–382
Wallace S, Whiting B, Runcie J (1976) Factors affecting drug binding in plasma of elderly patients. Br J Clin Pharmacol 3: 327–330
Wiegand VW, Hintze KL, Slattery JT, Levy G (1980) Protein binding of several drugs in serum and plasma of healthy subjects. Clin Pharmacol Ther 27: 297–300
Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390
Woodford-Williams E, Alvarez D, Webster B, Kandless B, Dixon MP (1964) Serum protein patterns in normal and pathological aging. Gerontologia 10: 86–99
Yacobi A, Stoll RG, DiSanto AR, Levy G (1976) Intersubject variation of warfarin binding to protein in serum of normal subjects. Res Commun Chem Pathol Pharmacol 14: 743–746
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verbeeck, R.K., Cardinal, J.A. & Wallace, S.M. Effect of age and sex on the plasma binding of acidic and basic drugs. Eur J Clin Pharmacol 27, 91–97 (1984). https://doi.org/10.1007/BF02395213
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02395213